Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Cold weather can significantly worsen multiple sclerosis symptoms, triggering stiffness, fatigue, and reduced mobility.

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Exposure to common environmental chemicals, especially in combination, is linked to an increased risk of multiple sclerosis.

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...